T Starck. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Cataract Extraction/adverse effectsFibrinolysis/drug effectsHumansHyphema/drug therapyHyphema/etiologyInjectionsPlasminogen Activators/therapeutic usePostoperative Complications/drug therapyRecombinant ProteinsTissue Plasminogen Activator/therapeutic use
Substances： See more » Recombinant ProteinsPlasminogen ActivatorsTissue Plasminogen Activator
Year: 1998 PMID： 9610435 DOI： 10.1016/s0886-3350(98)80246-0
Source DB: PubMed Journal: J Cataract Refract Surg ISSN： 0886-3350 Impact factor: 3.351